Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spatial profiling of cancer-associated fibroblasts of sporadic early onset colon cancer microenvironment. | NPJ Precis Oncol | 2023 | 37964075 | PubTator, text mining | PubMed |
| Regulation of Macronutrients in Insulin Resistance and Glucose Homeostasis during Type 2 Diabetes Mellitus. | Nutrients | 2023 | 37960324 | PubTator, text mining | PubMed |
| Src Tyrosine Kinase Inhibitory and Antioxidant Activity of Black Chokeberry and Bilberry Fruit Extracts Rich in Chlorogenic Acid. | Int J Mol Sci | 2023 | 37958496 | PubTator, text mining | PubMed |
| Development of a potency assay for CD34+ cell-based therapy. | Sci Rep | 2023 | 37952030 | PubTator, text mining | PubMed |
| Antibody-mediated spike activation promotes cell-cell transmission of SARS-CoV-2. | PLoS Pathog | 2023 | 37948454 | PubTator, text mining | PubMed |
| Five Inhibitory Receptors Display Distinct Vesicular Distributions in Murine T Cells. | Cells | 2023 | 37947636 | PubTator, text mining | PubMed |
| Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice. | Cell Commun Signal | 2023 | 37946301 | PubTator, text mining | PubMed |
| Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP. | BMJ Open | 2023 | 37940151 | PubTator, text mining | PubMed |
| [Mechanism of Qingluo Tongbi Formula for regulating immune-bone erosion in rheumatoid arthritis]. | Nan Fang Yi Ke Da Xue Xue Bao | 2023 | 37933646 | PubTator, text mining | PubMed |
| Immune inhibitory receptor-mediated immune response, metabolic adaptation, and clinical characterization in patients with COVID-19. | Sci Rep | 2023 | 37932287 | PubTator, text mining | PubMed |
| Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors. | Front Immunol | 2023 | 37928556 | PubTator, text mining | PubMed |
| Helicobacter pylori infection: a dynamic process from diagnosis to treatment. | Front Cell Infect Microbiol | 2023 | 37928189 | PubTator, text mining | PubMed |
| Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation. | Front Immunol | 2023 | 37915578 | PubTator, text mining | PubMed |
| Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function. | Front Immunol | 2023 | 37908353 | PubTator, text mining | PubMed |
| Biological function and clinical application prospect of tsRNAs in digestive system biology and pathology. | Cell Commun Signal | 2023 | 37904174 | PubTator, text mining | PubMed |
| Single-cell transcriptomics uncover hub genes and cell-cell crosstalk in patients with hypertensive nephropathy. | Int Immunopharmacol | 2023 | 37897949 | PubTator, text mining | PubMed |
| Unraveling DPP4 Receptor Interactions with SARS-CoV-2 Variants and MERS-CoV: Insights into Pulmonary Disorders via Immunoinformatics and Molecular Dynamics. | Viruses | 2023 | 37896834 | PubTator, text mining | PubMed |
| Guttapercha Improves In Vitro Bioactivity and Dentin Remineralization Ability of a Bioglass Containing Polydimethylsiloxane-Based Root Canal Sealer. | Molecules | 2023 | 37894568 | PubTator, text mining | PubMed |
| Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment. | Biomedicines | 2023 | 37892995 | PubTator, text mining | PubMed |
| Evaluation of the serum tRNA-derived fragment tRF-5022B as a potential biomarker for the diagnosis of osteoarthritis. | J Orthop Surg Res | 2023 | 37880787 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=13